LEMKEY JOHN G (Chief Financial Officer) received a stock award from ODONATE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/3/2020ACC: 0001209191-20-015070
Officer· Chief Financial Officer
Since Jun 2018
+94.00
Net shares
Net buyer
$1.2K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
94.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+47.00
Price / share
$25.15
Trade value
$1.18K
% of position
2.0%
2/28/2020
2.36K→2.41K
Total
Net shares
+47.00
Net value
$1.18K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/28/2020 | A · Award | +47.00 | $25.15 | $1.18K | 2.0% | 2.36K | 2.41K |
| Total | +47.00 | $1.18K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
47.00 shares
Shares
+47.00
Strike price
29.59
Held after
47.00
Exercisable
—
2/28/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock47.00 shares | 2/28/2020 | A · Award | +47.00 | 29.59 | — | 47.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned14.08M
Total
14.08M indirect14.08M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 14.08M | Indirect |
| Total | 14.08M | 14.08M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported